🛒 Buy Repatha Evolocumab (140 mg/mL) Injection Online – GlobMedIndia United Kingdom - London, Sheffield, Manchester, Bristol, Cambridge, Oxford, Cardiff, Leicester, USA, UK, UAE Australia, Europe, United Kingdom, United States, Cambridge, London, Morocco, Indonesia, Chile, Peru, Ethiopia, Romania, China, Japan, Russia, Ukraine, Dubai, United Arab Emirates, South Korea, Africa, Thailand, Vietnam, Middle East, and Southeast Asian countries. - GLOB MED INDIA PHARMA EXPORTER,South Africa

🩺 Repatha Evolocumab (140 mg/mL) Injection

🔹 Introduction

Repatha (Evolocumab 140 mg/mL Injection) is a prescription biologic medicine used to lower “bad cholesterol” (LDL-C) and reduce the risk of serious cardiovascular events such as heart attack and stroke.

It belongs to a class of drugs called PCSK9 inhibitors, which help the body remove excess cholesterol from the blood more effectively.

🔬 Composition & Content

Active Ingredient: Evolocumab (140 mg/mL)
Drug Class: Monoclonal antibody (PCSK9 inhibitor)
Inactive Ingredients:
- Proline
- Acetic acid
- Polysorbate 80
- Sodium hydroxide
- Water for injection

👉 Evolocumab works by blocking the PCSK9 protein, increasing LDL receptor availability in the liver and enhancing cholesterol clearance.

⚙️ How It Works (Mechanism)

PCSK9 normally destroys LDL receptors
Evolocumab blocks PCSK9
More LDL receptors → More cholesterol removed from blood
✔ Result: Significant reduction in LDL cholesterol levels

💉 How to Use

Administered as a subcutaneous injection (under the skin)
Injection sites:
- Abdomen
- Thigh
- Upper arm
Available forms:
- Prefilled syringe
- Autoinjector pen

✔ Patients can self-inject after proper training.

📊 Dosage

Typical adult dosing:

140 mg every 2 weeks
OR
420 mg once monthly

✔ Dosage depends on:

Cholesterol levels
Cardiovascular risk
Doctor’s recommendation

🩹 Uses & Treatments

Repatha is prescribed for:

✔ Cholesterol Management

Primary hyperlipidemia
Familial hypercholesterolemia (HeFH / HoFH)

✔ Cardiovascular Protection

Reduces risk of:
- Heart attack
- Stroke
- Coronary revascularization procedures

🌟 Advantages

Powerful LDL reduction (up to ~60%)
Suitable for statin-intolerant patients
Reduces major cardiovascular risks
Long-acting (biweekly or monthly dosing)
Minimal drug interactions

⚠️ Side Effects (Common)

Injection site reactions
Flu-like symptoms
Upper respiratory infections
Back pain

Rare:

Allergic reactions
Slight increase in blood sugar

🌡️ Storage Conditions

Store at 2°C to 8°C (refrigerated)
Do not freeze or shake
Can be kept at room temperature (up to 25°C) for 30 days
Protect from light

🔄 Alternative Brands / Medicines (Same or Similar Composition)

⚠️ Exact same molecule (Evolocumab):

Currently, Repatha is the primary global brand (no widely available biosimilar yet)

✔ Alternative PCSK9 Inhibitors (Similar Action)

Praluent (Alirocumab)
Leqvio (Inclisiran – siRNA-based PCSK9 inhibitor)

✔ Other Lipid-Lowering Options (India)

Rosuvastatin tablets (various Indian brands)
Atorvastatin
Ezetimibe combinations

🇮🇳 Alternative Indian Brands / Availability

Evolocumab is imported biologic, limited Indian brands
Available via:
Specialty pharmacies
Oncology & cardiology distributors
Exporters like GlobMedIndia

✅ Conclusion

Repatha Evolocumab 140 mg Injection is a highly advanced and effective therapy for managing high cholesterol and preventing cardiovascular complications, especially in patients who do not respond to conventional treatments like statins. Its targeted mechanism, strong efficacy, and convenient dosing make it a preferred choice in modern cardiology.